CAS 41613-16-5

C8 Galactosylceramide (d18:1/8:0)

CAS: 41613-16-5

C8 Galactosylceramide boosts doxorubicin efficacy in cancer cells, not healthy ones, and affects splenocyte growth and cytokine release at 100-1,000 ng/ml.

Formel: C₃₂H₆₁NO₈

Farbe und Form: Solid

Molekulargewicht: 587.83

Ref: TM-T36323

Octanoyl-Galactosylceramide

CAS: 41613-16-5

Formel: C32H61NO8

Reinheit: >99%

Farbe und Form: Solid

Molekulargewicht: 587.83

Ref: 48-56-2061